Building on the phenomenal accomplishments in an exceptionally challenging year, IFAPP Academy is expanding its global communications outreach in 2021 as the fountainhead in education and training in medicines development.
To champion this cause, the elite cadre of biopharmaceuticals professionals convened under the banner of an Editorial Board. The board was designated as IFAPP Academy’s Scientific Advisory Committee to reflect the considerably expanded remit and scope of oversight envisaged for learners’ burgeoning global community.
In alignment with IFAPP Academy and IFAPP governance, the Scientific Advisory Committee, chaired by Pravin Chopra, will drive the strategic communications framework and guidance for engaging key stakeholders. The Committee will oversee the Academy’s growing Value-Added Programs and Services offerings and direct the Academy’s external scientific exchange platforms aspiring to inform, educate, and engender dialogue on trending topics and advancements in biopharmaceutical medicines development and medical affairs.
The ongoing pandemic has fueled the imperative for virtual connectivity and networking amongst patient advocates and biomedical professionals, and the Academy gratefully acknowledges the valued expertise, insights, and leadership of the Scientific Advisory Committee members as we enter a new era of healthcare innovation.
